The most recent report by Future Market Insights projects that the next-generation optical biometry equipment market sale will be worth US$ 320.7 million by 2021. The prevalence of eye illnesses including cataracts and refractive errors, as well as the rise in eye clinics and hospitals across the globe, are driving up the adoption of next-generation optical biometry technology.
Sales of next-generation optical biometry equipment are predicted to increase at a CAGR of 5.4% to reach US$ 461.3 million by 2028. In 2021, the global market for ophthalmic imaging devices accounted for 16.1% of shipments of next-generation optical biometry equipment. The majority of revenue generated by the newest optical biometry equipment (41.8%) comes from hospitals.
With the advancement in technology, next-generation optical biometry devices have been developed aiding the measurement of eyes before cataract and refractive surgeries. Earlier measurement by ultrasound technique was gold standard. However, unlike next-generation optical biometry devices, ultrasound devices require direct contact of the probe, which lead to many eye infections.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7556
According to Prevent Blindness organization, ~25 Mn Americans having cataract require medical care every year in the U.S., hence boosting demand for next generation optical biometry devices. Similar rising demand for next generation optical biometry devices is noted in UK with rising number of cataract surgeries. Increased demand for next generation optical biometry devices is noted in developing markets concurrent with access to eye care facilities. Next generation optical biometry devices are all-in one devices used for evaluation of lens and refraction, of retina.
Next Generation Optical Biometry Devices Market: Overview & Analysis
Rapid increase in number of probe infections due to usage of ultrasound devices, lead to post-operative errors fuelling demand for next generation optical biometry devices instead of ultrasound biometry devices. Manufacturers of next generation optical biometry devices are introducing automated devices which are more efficient in measuring segments of eyes. Players in next generation optical biometry devices market are working on strengthening the software, which could provide detailed information about eye segments. New next generation optical biometry devices introduced are taking into account irregularities and astigmatisms of the anterior and the posterior surfaces of the eye. The next generation optical biometry devices uses a partially coherent wave that has approximately 9x the resolution of a 10 MHz sound wave, for precise measurement of axial length.
Hospitals end users segment account for 41.8% revenue share in the global Next Generation Optical biometry Devices market. Medical services and vision benefits offered under Medicare includes cataract surgeries; which will increase the demand of next generation optical biometry devices.
The company has segmented the global Next Generation Optical Biometry Devices Market into product type and end users. In terms of revenue, the swept source segment in product type in next generation optical biometry devices market report will account for significant revenue share over the forecast period. In contrary, the Partial coherence interferometry (PCI) based next generation optical biometry devices segment in all the markets will exhibit limited investment opportunities through 2028 in next generation optical biometry devices market.
Key Companies Profiled
- Nidek Co Ltd.
- Ziemer Ophthalmic Systems
- TOMEY GmbH
- Movu Inc.
- OCULUS Optikgeräte GmbH.
- Bausch & Lomb Incorporated
- Topcon Corporation
- Heine Optotechnik GmbH & Co. KG
- AMETEK, Inc.
- Optovue, Incorporated
- Leica Microsystems GmbH
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7556
Key Segments of Next Generation Optical Biometry Devices Industry Survey
Next-Generation Optical Biometry Devices Market by Product Type
- Swept-Source Optical Coherence Tomography (OCT) Based Biometers
- Partial Coherence Interferometry (PCI) Based Biometers
- Optical Low Coherence Reflectometry (OLCR) Based Biometers
Next-Generation Optical Biometry Devices Market by End User
- Hospitals
- Ophthalmology Clinics and Specialized Eye Care Centers
- Ambulatory Surgical Centers
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube